GALLIVAC REO
GALLIVAC REO
Not authorised
- Avian reovirus, strain S1133, Live
Product identification
Medicine name:
GALLIVAC REO
Active substance:
- Avian reovirus, strain S1133, Live
Target species:
-
Chicken (for reproduction)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Avian reovirus, strain S1133, Live5.20/log10 cell culture infective dose 50/dose1.00dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Chicken (for reproduction)
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD10
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Romania
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health Italia S.p.A.
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 120234
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 12/04/2022
How useful was this page?:
